Kewaunee Scientific Corporation
KEQU
$34.15
-$0.12-0.35%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.32% | 46.75% | 46.93% | 36.06% | 43.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.32% | 46.75% | 46.93% | 36.06% | 43.59% |
| Cost of Revenue | 4.23% | 48.99% | 39.74% | 26.27% | 40.40% |
| Gross Profit | 0.90% | 41.34% | 67.60% | 64.19% | 52.79% |
| SG&A Expenses | -1.03% | 64.04% | 62.61% | 70.41% | 95.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.93% | 52.29% | 44.69% | 34.13% | 50.92% |
| Operating Income | 14.76% | -7.37% | 86.80% | 53.93% | -40.24% |
| Income Before Tax | 25.80% | -12.16% | 61.32% | 430.73% | -63.73% |
| Income Tax Expenses | 588.89% | -0.11% | 296.35% | 122.40% | -111.00% |
| Earnings from Continuing Operations | -22.20% | -15.82% | 41.15% | -55.75% | -45.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1,224.14% | -1,228.57% | -46.67% | 36.60% | -141.67% |
| Net Income | -48.89% | -18.72% | 41.04% | -56.01% | -46.29% |
| EBIT | 14.76% | -7.37% | 86.80% | 53.93% | -40.24% |
| EBITDA | 9.60% | 8.53% | 87.58% | 54.46% | -16.78% |
| EPS Basic | -48.77% | -18.55% | 40.95% | -55.95% | -45.90% |
| Normalized Basic EPS | -19.30% | -15.52% | 61.65% | 36.76% | -64.59% |
| EPS Diluted | -48.89% | -18.81% | 40.54% | -56.06% | -47.06% |
| Normalized Diluted EPS | -19.15% | -16.16% | 61.99% | 36.15% | -65.21% |
| Average Basic Shares Outstanding | -0.21% | -0.21% | 0.07% | -0.14% | -0.73% |
| Average Diluted Shares Outstanding | -0.40% | 0.54% | -0.13% | 0.30% | 1.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |